This study is accepting new patients by invitation only

Observational, Long-term, Extension Study for Participants of Prior VY-AADC01 or VY-AADC02 Studies

Description

An extension study for participants who have completed VY-AADC01 or VY-AADC02 Studies

An Observational, Long-Term Extension Study for Participants of Prior VY-AADC01 or VY-AADC02 Clinical Studies

Parkinson Disease PD Parkinson's Disease Aromatic L-Amino Acid Decarboxylase AADC AAV2 AAV2-AADC VY-AADC Dopa Decarboxylase

Open to people ages 40 years and up

Participant in Voyager-sponsored clinical study of VY-AADC01 or VY-AADC02 gene therapy
Ability to comprehend and signed the informed consent, or for participants who are not capable of providing consent, have a healthcare proxy, or person with power of attorney, who is able and willing to give consent on behalf of the participant
Capable of complying with the protocol

None

University of California, San Francisco
San Francisco California 94143 United States